We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Willing to Ease Postmarket Burdens to Get Support for Quality by Design
The item has been added to your shopping cart.
FDA Willing to Ease Postmarket Burdens to Get Support for Quality by Design
October 6, 2006
The FDA is taking steps to introduce more regulatory flexibility into postmarket reviews in order to get industry's support for the agency's Quality by Design (QbD) initiative, officials said.